|
PHACTR2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.333900E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.788300E-02 |
| Normal-vs-Stage2 |
3.871900E-02 |
| Normal-vs-Stage3 |
2.467600E-01 |
| Normal-vs-Stage4 |
4.081600E-02 |
| Stage1-vs-Stage2 |
6.540400E-01 |
| Stage1-vs-Stage3 |
7.750200E-01 |
| Stage1-vs-Stage4 |
2.226800E-01 |
| Stage2-vs-Stage3 |
5.252400E-01 |
| Stage2-vs-Stage4 |
3.760600E-01 |
| Stage3-vs-Stage4 |
1.887570E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.857100E-03 |
| Normal-vs-AfricanAmerican |
7.523800E-01 |
| Normal-vs-Asian |
5.115900E-03 |
| Caucasian-vs-AfricanAmerican |
5.118000E-02 |
| Caucasian-vs-Asian |
3.366600E-01 |
| AfricanAmerican-vs-Asian |
1.289040E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.065730E-02 |
| Normal-vs-Female |
3.627000E-01 |
| Male-vs-Female |
2.646400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.800180E-01 |
| Normal-vs-Extreme_Weight |
4.803300E-04 |
| Normal-vs-Obese |
2.237800E-01 |
| Normal-vs-Extreme_Obese |
1.406180E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.404200E-01 |
| Normal_Weight-vs-Obese |
6.104600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.008200E-01 |
| Extreme_Weight-vs-Obese |
7.858600E-03 |
| Extreme_Weight-vs-Extreme_Obese |
4.351600E-01 |
| Obese-vs-Extreme_Obese |
5.647600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.643800E-02 |
| Normal-vs-Age(41-60Yrs) |
4.458800E-01 |
| Normal-vs-Age(61-80Yrs) |
3.778600E-03 |
| Normal-vs-Age(81-100Yrs) |
6.764000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.205610E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.415200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.671800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.996300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.508610E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.996200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.998300E-02 |
| Normal-VS-Type2 PRCC |
4.027800E-02 |
| Normal-VS-KIRP CIMP |
1.284160E-03 |
| Normal-VS-Unclassified PRCC |
7.604000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.529000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.031620E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.065800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.019960E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.522200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.476900E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.267800E-02 |
| Normal-vs-N1 |
6.013500E-02 |
| Normal-vs-N2 |
2.321800E-03 |
| N0-vs-N1 |
9.743400E-01 |
| N0-vs-N2 |
2.937200E-01 |
| N1-vs-N2 |
2.304400E-01 |
|
|
